Novel cardiovascular risk markers in depression: No association between depressive symptoms and osteoprotegerin or adiponectin in persons at high risk for sleep apnea

Journal of Affective Disorders

Volumn 145, Issue 3, 2013, Pages 400-404

  Einvik, Gunnar ^a   Flyvbjerg, Allan ^b,c   Hrubos Strøm, Harald ^a,d   Randby, Anna ^a   Frystyk, Jan ^b,c   Bjerre, Mette ^b,c   Namtvedt, Silje K ^a   Kristiansen, Håvard A ^e   Nordhus, Inger H ^f   Somers, Virend K ^g   Dammen, Toril ^d   Omland, Torbjørn ^a  

^a AKERSHUS UNIVERSITY HOSPITAL   (Norway)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

^c AARHUS UNIVERSITY   (Denmark)

^d Institute for Basal Medical Science   (Norway)

^e INNLANDET HOSPITAL TRUST   (Norway)

^f UNIVERSITY OF BERGEN   (Norway)

^g MAYO CLINIC   (United States)

Author keywords

Adiponectin; Beck depression inventory; C reactive protein; Major depressive disorder; Obstructive sleep apnea; Osteoprotegerin

Indexed keywords

ADIPONECTIN; ANTIDEPRESSANT AGENT; ANTIINFLAMMATORY AGENT; C REACTIVE PROTEIN; OSTEOPROTEGERIN;

ADULT; ANAMNESIS; ARTICLE; BECK DEPRESSION INVENTORY; BLOOD CHEMISTRY; BLOOD SAMPLING; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL ASSESSMENT; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DEPRESSION; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; FLUOROMETRY; HIGH RISK PATIENT; HUMAN; IMMUNOASSAY; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK FACTOR; SENSITIVITY AND SPECIFICITY; SLEEP DISORDERED BREATHING; STRUCTURED INTERVIEW; SYMPTOM; TIME RESOLVED IMMUNOFLUOROMETRIC ASSAY; VENOUS BLOOD;

ADIPONECTIN; ADULT; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CROSS-SECTIONAL STUDIES; DEPRESSION; DEPRESSIVE DISORDER, MAJOR; FEMALE; HUMANS; MALE; MIDDLE AGED; OSTEOPROTEGERIN; PSYCHIATRIC STATUS RATING SCALES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SLEEP APNEA, OBSTRUCTIVE;

EID: 84873204986     PISSN: 01650327     EISSN: 15732517     Source Type: Journal    
DOI: 10.1016/j.jad.2012.05.065     Document Type: Article

References (30)

1. K.K. Andersen, J. Frystyk, O.D. Wolthers, C. Heuck, and A. Flyvbjerg Gender differences of oligomers and total adiponectin during puberty: a cross-sectional study of 859 Danish school children The Journal of Clinical Endocrinology and Metabolism 92 5 2007 1857 1862
2. Beck,A.C.; Steer,R.A.; 1987. Manual for the Beck Depression Inventory. The Psychological Corporation, San Antonio.
3. K. Brochu-Gaudreau, C. Rehfeldt, R. Blouin, V. Bordignon, B.D. Murphy, and M.F. Palin Adiponectin action from head to toe Endocrine 37 1 2010 11 32
4. K. Caidahl, T. Ueland, and P. Aukrust Osteoprotegerin: a biomarker with many faces Arteriosclerosis, Thrombosis, and Vascular Biology 30 9 2010 1684 1686
5. G. Cizza, V.T. Nguyen, F. Eskandari, Z. Duan, E.C. Wright, J.C. Reynolds, R.S. Ahima, and M.R. Blackman Low 24-hour adiponectin and high nocturnal leptin concentrations in a case-control study of community-dwelling premenopausal women with major depressive disorder: the Premenopausal, Osteopenia/ Osteoporosis, Women, Alendronate, Depression (POWER) study Journal of Clinical Psychiatry 71 8 2010 1079 1087
6. F. Faul, E. Erdfelder, A.G. Lang, and A. Buchner G Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences Behavior Research Methods 39 2 2007 175 191
7. M.B. First, R.L. Spitzer, M. Gibbon, and J.B. Williams Structured Clinical Interview for DSM-IV Axis I Disorders, Clinician Version 1996 American Psychiatric Press Inc. Washington D.C.
8. A. Flyvbjerg Diabetic angiopathy, the complement system and the tumour necrosis factor superfamily Nature Reviews Endocrinology 6 2010 94 110
9. M.B. Howren, D.M. Lamkin, and J. Suls Associations of depression with C-reactive protein, IL-1, and IL-6: A meta-analysis Psychosomatic Medicine 71 2 2009 171 186
10. H. Hrubos-Strøm, A. Randby, S.K. Namtvedt, H.A. Kristiansen, G. Einvik, J. Saltyte-Benth, V.K. Somers, I.H. Nordhus, M. Russel, T. Dammen, T. Omland, and K. Kværner A Norwegian population-based study on the risk and prevalence of obstructive sleep apnea: the Akershus Sleep Apnea Project (ASAP) Journal of Sleep Research 20 1 Pt 2 2011 162 170
11. K.G. Kahl, W. Greggersen, S. Rudolf, B.M. Stoeckelhuber, C.U. Bergmann-Koester, L. Dibbelt, and U. Schweiger Bone mineral density, bone turnover, and osteoprotegerin in depressed women with and without borderline personality disorder Psychosomatic Medicine 68 5 2006 669 674
12. K.G. Kahl, S. Rudolf, L. Dibbelt, B.M. Stoeckelhuber, H.B. Gehl, F. Hohagen, and U. Schweiger Decreased osteoprotegerin and increased bone turnover in young female patients with major depressive disorder and a lifetime history of anorexia nervosa Osteoporosis International 16 4 2005 424 429
13. P. Khalili, A. Flyvbjerg, J. Frystyk, F. Lundin, J. Jendle, G. Engstrom, and P.M. Nilsson Total adiponectin does not predict cardiovascular events in middle-aged men in a prospective, long-term follow-up study Diabetes Metabolism 36 2 2010 137 143
14. G.A. Laughlin, E. Barrett-Connor, S. May, and C. Langenberg Association of adiponectin with coronary heart disease and mortality: the Rancho Bernardo study American Journal of Epidemiology 165 2 2007 164 174
15. S.M. Lehto, A. Huotari, L. Niskanen, T. Tolmunen, H. Koivumaa-Honkanen, K. Honkalampi, H. Ruotsalainen, K.H. Herzig, H. Viinamaki, and J. Hintikka Serum adiponectin and resistin levels in major depressive disorder Acta Psychiatrica Scandinavica 121 3 2010 209 215
16. R. Leo, L.G. Di, M. Tesauro, C. Cola, E. Fortuna, M. Zanasi, A. Troisi, A. Siracusano, R. Lauro, and F. Romeo Decreased plasma adiponectin concentration in major depression Neuroscience Letters 407 3 2006 211 213
17. A. Nadjar, R.M. Bluthe, M.J. May, R. Dantzer, and P. Parnet Inactivation of the cerebral NFkappaB pathway inhibits interleukin-1beta-induced sickness behavior and c-Fos expression in various brain nuclei Neuropsychopharmacology 30 8 2005 1492 1499
18. N.C. Netzer, R.A. Stoohs, C.M. Netzer, K. Clark, and K.P. Strohl Using the Berlin questionnaire to identify patients at risk for the sleep apnea syndrome Annals of Internal Medcine 131 7 1999 485 491
19. A. Nicholson, H. Kuper, and H. Hemingway Depression as an aetiologic and prognostic factor in coronary heart disease: a meta-analysis of 6362 events among 146 538 participants in 54 observational studies European Heart Journal 27 23 2006 2763 2774
20. T. Omland, T. Ueland, A.M. Jansson, A. Persson, T. Karlsson, C. Smith, J. Herlitz, P. Aukrust, M. Hartford, and K. Caidahl Circulating osteoprotegerin levels and long-term prognosis in patients with acute coronary syndromes Journal of the American College of Cardiology 51 6 2008 627 633
21. A. Pan, X. Ye, O.H. Franco, H. Li, Z. Yu, J. Wang, Q. Qi, W. Gu, X. Pang, H. Liu, and X. Lin The association of depressive symptoms with inflammatory factors and adipokines in middle-aged and older Chinese PLoS One 3 1 2008 e1392
22. C.L. Raison, L. Capuron, and A.H. Miller Cytokines sing the blues: inflammation and the pathogenesis of depression Trends in Immunology 27 1 2006 24 31
23. L.M. Rasmussen, L. Tarnow, T.K. Hansen, H.-H. Parning, and A. Flyvbjerg Associations between plasma osteoprotegerin, glycaemic status, systolic blood pressure, and cardiovascular morbidity in type 1 diabetic patients with and without nephropathy European Journal of Endocrinology 154 2006 75 81
24. A. Rechtshaffen, and A. Kales A manual of standardized terminology and scoring system for sleep stages of human sleep 1968 University of California at Los Angeles Los Angeles, CA Brain Information Service/Brain Research Institute
25. A.G. Semb, T. Ueland, P. Aukrust, N.J. Wareham, R. Luben, L. Gullestad, J.J. Kastelein, K.T. Khaw, and S.M. Boekholdt Osteoprotegerin and soluble receptor activator of nuclear factor-kappaB ligand and risk for coronary events: a nested case-control approach in the prospective EPIC-Norfolk population study 1993-2003 Arteriosclerosis, Thrombosis, and Vascular Biology 29 6 2009 975 980
26. K.G. van der Kooy, H. van Hout, H. Marwijk, H. Marten, C. Stehouwer, and A. Beekman Depression and the risk for cardiovascular diseases: systematic review and meta analysis International Journal of Geriatric Psychiatry 22 7 2007 613 626
27. S.G. Wannamethee, P. Welsh, P.H. Whincup, N. Sawar, M.C. Thomas, V. Gudnarsson, and N. Sattar High adiponectin and increased risk of cardiovascular disease and mortality in asymptomatic older men: does NT-proBNP help to explain this association? European Journal of Preventive Cardiology 18 1 2011 65 71
28. M.A. Whooley, C.M. Caska, B.E. Hendrickson, M.A. Rourke, J. Ho, and S. Ali Depression and inflammation in patients with coronary heart disease: findings from the heart and soul study Biological Psychiatry 62 4 2007 314 320
29. E.D. Williams, and A. Steptoe The role of depression in the etiology of acute coronary syndrome Current Psychiatry Reports 9 6 2007 486 492
30. M. Zeman, R. Jirak, M. Jachymova, M. Vecka, E. Tvrzicka, and A. Zak Leptin, adiponectin, leptin to adiponectin ratio and insulin resistance in depressive women Neuro Endocrinology Letters 30 3 2009 387 395